Cargando…

Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy

Chimeric antigen receptor (CAR) T-cell therapy has produced remarkable anti-tumor responses in patients with B-cell malignancies. However, clonal kinetics and transcriptional programs that regulate the fate of CAR-T cells after infusion remain poorly understood. Here we perform TCRB sequencing, inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheih, Alyssa, Voillet, Valentin, Hanafi, Laïla-Aïcha, DeBerg, Hannah A., Yajima, Masanao, Hawkins, Reed, Gersuk, Vivian, Riddell, Stanley R., Maloney, David G., Wohlfahrt, Martin E., Pande, Dnyanada, Enstrom, Mark R., Kiem, Hans-Peter, Adair, Jennifer E., Gottardo, Raphaël, Linsley, Peter S., Turtle, Cameron J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954177/ https://www.ncbi.nlm.nih.gov/pubmed/31924795 http://dx.doi.org/10.1038/s41467-019-13880-1

Ejemplares similares

Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
por: Radtke, Stefan, et al.
Publicado: (2023)

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
por: Liang, Emily C., et al.
Publicado: (2023)

Intracellular RNase activity dampens zinc finger nuclease-mediated gene editing in hematopoietic stem and progenitor cells
por: Peterson, Christopher W., et al.
Publicado: (2021)

Purification of Human CD34(+)CD90(+) HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy
por: Radtke, Stefan, et al.
Publicado: (2020)

Cytokines in CAR T Cell–Associated Neurotoxicity
por: Gust, Juliane, et al.
Publicado: (2020)

P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
por: Liang, Emily, et al.
Publicado: (2023)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data
por: Finak, Greg, et al.
Publicado: (2015)

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
por: Vainstein, Vladimir, et al.
Publicado: (2023)

Conventional CARs versus modular CARs
por: Feldmann, Anja, et al.
Publicado: (2019)

2711. Viral encephalitis after chimeric antigen receptor (CAR)-modified T-cell therapy: A Retrospective Cohort Study
por: Kampouri, Eleftheria, et al.
Publicado: (2023)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

Motor Cars for Doctors: Cars Suitable for Practitioners
Publicado: (1906)

CERN cars at car sharing point on the Meyrin site
por: Andrade, Rui
Publicado: (2022)

Motor Cars for Doctors: Hints on Buying a Car
Publicado: (1906)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Engineering switchable and programmable universal CARs for CAR T therapy
por: Liu, Delong, et al.
Publicado: (2019)

Universal CARs, universal T cells, and universal CAR T cells
por: Zhao, Juanjuan, et al.
Publicado: (2018)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
por: Arjomandnejad, Motahareh, et al.
Publicado: (2022)

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy
por: Juluri, Krishna R., et al.
Publicado: (2022)

The making and function of CAR cells
por: Zabel, Maja, et al.
Publicado: (2019)

Car Club
por: Automobile Club
Publicado: (2012)

Car Club
por: Automobile club
Publicado: (2013)

CAR CLUB
por: Car Club
Publicado: (2012)

Car Observations
Publicado: (1859)

Eating in the Cars
Publicado: (1871)

Riding in the Cars
por: Weybridge, W.
Publicado: (1860)

Eating in the Cars
Publicado: (1885)

Reading on the Cars
Publicado: (1872)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Changes in private car ownership associated with car sharing: gauging differences by residential location and car share typology
por: Jain, Taru, et al.
Publicado: (2021)

Stem cell–derived CAR T cells traffic to HIV reservoirs in macaques
por: Barber-Axthelm, Isaac M., et al.
Publicado: (2021)

Tagmentation-based analysis reveals the clonal behavior of CAR-T cells in association with lentivector integration sites
por: Kim, Jaeryuk, et al.
Publicado: (2023)

Clinical Implications and Dynamics of Clonal Hematopoiesis in Anti-CD19 CAR T-cell Treated Patients
por: Panagiota, Victoria, et al.
Publicado: (2023)

Transportation: Travel by Air, Car, and Train
por: Tarlow, Peter E.
Publicado: (2014)

196. Antibodies to Vaccine-preventable Infections After CAR-T Cell Immunotherapy for B Cell Malignancies
por: Walti, Carla S, et al.
Publicado: (2020)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
por: Kim, Gloria B., et al.
Publicado: (2019)

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL
por: Zurko, Joanna, et al.
Publicado: (2022)

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy
por: Walti, Carla S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ankvkj6td7ctbrslc84oohnjb